Skip to main content
DNA strand

HEMGENIX®

Have a Question? Use Our New Chat Feature! Chat with our Medical Information Specialists by clicking on the Chat with us now available in the lower right corner of this screen.

Educational Materials

Gene Therapy Mechanism of Action

Learn about the mechanism of action (MOA) for gene therapy in hemophilia, in which liver-directed gene transfer introduces a therapeutic gene to achieve durable expression of functional factor protein to restore hemostasis.

HEMGENIX_HOPE-B 3-Year Data_Illustration_CSL Medical Affairs

HEMGENIX HOPE-B 3-Year Data Illustration

An educational illustration highlighting the 3-year data for the HOPE-B clinical trial for etranacogene dezaparvovec-drlb. The data includes results for bleeds, factor IX activity levels, factor consumption, and safety.

Preparation and Administration

HEMGENIX should only be prepared and administered by trained staff at an administration center. Please refer to the full Prescribing Information for detailed steps on preparation and administration of HEMGENIX.

Ancillary Supplies Flashcard

HEMGENIX Ancillary Supplies Flashcard

For U.S. Healthcare Professionals only
For U.S. Healthcare Professionals only

The purpose of this CSL Behring Medical Affairs website is to support U.S. Healthcare Professionals with scientific information. This website is also a channel for U.S. Healthcare Professionals to submit questions or connect with CSL Behring U.S. Healthcare Professionals. The information provided is for educational purposes only and is not intended to promote any products. By continuing to use this site you are acknowledging that you are a U.S. Healthcare Professional

toggle chat overlay
toggle chat overlay